Sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes : a review of clinical effectiveness, cost-effectiveness, and guidelines

This report aims to summarize the comparative clinical effectiveness and comparative cost-effectiveness of sodium-glucose co-transporter 2 inhibitors for the treatment of adults with type 2 diabetes, as well as relevant evidence-based guidelines for the pharmacologic management of diabetes

Main Authors: Amanda, Shane, Butcher, Robyn (Author)
Corporate Authors: Canadian Agency for Drugs and Technologies in Health, Canadian Agency for Drugs and Technologies in Health Rapid Response Service
Format: eBook
Language:English
Published: Ottawa CADTH June 14, 2019, 2019
Edition:Version: 1.0
Series:CADTH rapid response report
Subjects:
Online Access:
Collection: National Center for Biotechnology Information - Collection details see MPG.ReNa
Summary:This report aims to summarize the comparative clinical effectiveness and comparative cost-effectiveness of sodium-glucose co-transporter 2 inhibitors for the treatment of adults with type 2 diabetes, as well as relevant evidence-based guidelines for the pharmacologic management of diabetes
Physical Description:1 PDF file (39 pages) illustration